<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: To investigate the relationships of <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> to <z:hpo ids='HP_0000001'>all</z:hpo>-cause and <z:mp ids='MP_0002055'>diabetes</z:mp>-related mortality in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> after controlling for significant correlates </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We examined 326 patients diagnosed as diabetic <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo> by nerve conduction study in Keelung city, Taiwan, in 2002 and followed them up to ascertain the cause and date of <z:hpo ids='HP_0011420'>death</z:hpo> until the end of 2006 </plain></SENT>
<SENT sid="2" pm="."><plain>The cause and date of <z:hpo ids='HP_0011420'>death</z:hpo> were recorded for the deceased patients </plain></SENT>
<SENT sid="3" pm="."><plain>Information on significant correlates in association with diabetic <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo> and <z:hpo ids='HP_0000001'>all</z:hpo>-cause and <z:mp ids='MP_0002055'>diabetes</z:mp>-related mortality was also collected </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: With median follow-up time of 62.28 months, 44 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> died </plain></SENT>
<SENT sid="5" pm="."><plain>The cause of <z:hpo ids='HP_0011420'>death</z:hpo> related to <z:mp ids='MP_0002055'>diabetes</z:mp> accounted for 59% (n = 26) of the deceased </plain></SENT>
<SENT sid="6" pm="."><plain>Univariate analysis shows that the presence of <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> confers higher risk for <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality (hazard ratio [HR] = 4.88) and mortality from <z:mp ids='MP_0002055'>diabetes</z:mp> (HR = 6.58) </plain></SENT>
<SENT sid="7" pm="."><plain>The significant finding still persisted after adjustment for age, gender, blood pressure, smoking, history of cardiovascular/cerebrovascular disease, duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, waist circumference, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, total cholesterol, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, and <z:chebi fb="0" ids="16737">creatinine</z:chebi> (adjusted HR = 4.44 for <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0011420'>death</z:hpo> and adjusted HR = 11.82 for <z:mp ids='MP_0002055'>diabetes</z:mp>-related mortality, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Diabetic <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo> was an independent predictor for <z:hpo ids='HP_0000001'>all</z:hpo>-cause and <z:mp ids='MP_0002055'>diabetes</z:mp>-related mortality </plain></SENT>
<SENT sid="9" pm="."><plain>The presence of <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> together with other significant prognostic factors is informative to predict <z:hpo ids='HP_0000001'>all</z:hpo>-cause <z:hpo ids='HP_0011420'>death</z:hpo> and <z:hpo ids='HP_0011420'>death</z:hpo> from <z:mp ids='MP_0002055'>diabetes</z:mp>-related disease for patients diagnosed as type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>